X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (686) 686
Publication (65) 65
Book Review (30) 30
Magazine Article (13) 13
Book / eBook (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (570) 570
index medicus (440) 440
female (348) 348
dentistry (319) 319
dentistry, oral surgery & medicine (302) 302
bone density conservation agents - adverse effects (290) 290
male (285) 285
necrosis (283) 283
diphosphonates - adverse effects (279) 279
osteonecrosis (266) 266
bones (255) 255
aged (238) 238
middle aged (224) 224
risk-factors (220) 220
bisphosphonates (208) 208
osteoporosis (208) 208
zoledronic acid (196) 196
bisphosphonate-associated osteonecrosis of the jaw - etiology (186) 186
surgery (173) 173
risk factors (172) 172
jaw (170) 170
prevention (159) 159
aged, 80 and over (140) 140
bisphosphonate-associated osteonecrosis (135) 135
bone density conservation agents - therapeutic use (132) 132
diphosphonates - therapeutic use (129) 129
bisphosphonate (122) 122
phosphonates (121) 121
osteoporosis - drug therapy (118) 118
cancer (117) 117
bisphosphonate-associated osteonecrosis of the jaw - prevention & control (115) 115
therapy (112) 112
bone density conservation agents - administration & dosage (109) 109
diphosphonates - administration & dosage (106) 106
bisphosphonate-related osteonecrosis (101) 101
bone (94) 94
retrospective studies (94) 94
adult (93) 93
cancer-patients (92) 92
denosumab (92) 92
care and treatment (88) 88
bisphosphonate-associated osteonecrosis of the jaw - pathology (85) 85
diphosphonates (84) 84
multiple-myeloma (84) 84
animals (83) 83
tooth extraction (83) 83
analysis (80) 80
bisphosphonate-associated osteonecrosis of the jaw (80) 80
bisphosphonate-associated osteonecrosis of the jaw - surgery (79) 79
management (78) 78
bisphosphonate-associated osteonecrosis of the jaw - therapy (75) 75
treatment outcome (74) 74
osteonecrosis of the jaw (73) 73
bisphosphonate-associated osteonecrosis of the jaw - diagnosis (72) 72
bisphosphonate-associated osteonecrosis of the jaw - epidemiology (70) 70
osteonecrosis - chemically induced (69) 69
health aspects (68) 68
surgeons position paper (68) 68
american association (67) 67
endocrinology & metabolism (66) 66
imidazoles - adverse effects (66) 66
alendronate (65) 65
medicine & public health (62) 62
rats (56) 56
drug therapy (55) 55
research (54) 54
oral bisphosphonates (53) 53
bronj (52) 52
jaws (51) 51
bisphosphonate-associated osteonecrosis of the jaw - diagnostic imaging (50) 50
bone neoplasms - drug therapy (50) 50
bone neoplasms - secondary (50) 50
oncology (50) 50
jaw diseases - chemically induced (48) 48
postmenopausal women (47) 47
medical research (44) 44
orthopedics (43) 43
abridged index medicus (41) 41
administration, oral (41) 41
association (41) 41
breast-cancer (41) 41
follow-up studies (41) 41
incidence (41) 41
disease models, animal (40) 40
imidazoles - administration & dosage (39) 39
medicine, general & internal (39) 39
bisphosphonate-associated osteonecrosis of the jaw - drug therapy (38) 38
patients (38) 38
zoledronate (38) 38
imidazoles - therapeutic use (37) 37
risk (37) 37
time factors (37) 37
diphosphonates - pharmacology (36) 36
metastasis (36) 36
pamidronate (36) 36
risk assessment (36) 36
alendronate - adverse effects (35) 35
bone density conservation agents (35) 35
bone metastases (35) 35
medicine, experimental (35) 35
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (658) 658
Japanese (9) 9
French (8) 8
Chinese (6) 6
Spanish (5) 5
Portuguese (4) 4
German (3) 3
Hungarian (3) 3
Polish (2) 2
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biomedical Materials Research - Part B Applied Biomaterials, ISSN 1552-4973, 07/2018, Volume 106, Issue 5, pp. 1799 - 1808
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2017, Volume 2017, Issue 10, p. CD012432
Background Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse reaction experienced by some individuals to certain medicines commonly used... 
ZOLEDRONIC ACID | HYPERBARIC-OXYGEN | MEDICINE, GENERAL & INTERNAL | CANCER-PATIENTS | METAANALYSIS | ORAL BISPHOSPHONATES | BONE METASTASES | BISPHOSPHONATE-RELATED OSTEONECROSIS | SURGICAL-MANAGEMENT | TOOTH EXTRACTION | PREVENTIVE MEASURES | Humans | Jaw Diseases - prevention & control | Jaw Diseases - therapy | Postoperative Complications - prevention & control | Male | Denosumab - adverse effects | Denosumab - therapeutic use | Tooth Extraction - adverse effects | Jaw Diseases - chemically induced | Anti-Bacterial Agents - therapeutic use | Time Factors | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Angiogenesis Inhibitors - adverse effects | Diphosphonates - adverse effects | Prostatic Neoplasms - drug therapy | Osteonecrosis - therapy | Bone Density Conservation Agents - adverse effects | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Postoperative Complications - therapy | Zoledronic Acid | Dental Care | Randomized Controlled Trials as Topic | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | Quality of Life | Intercellular Signaling Peptides and Proteins - therapeutic use | Oral Health | Osteonecrosis - chemically induced | Osteonecrosis - prevention & control | Bisphosphonate-Associated Osteonecrosis of the Jaw - prevention & control | Hyperbaric Oxygenation
Journal Article
International Journal of Oral & Maxillofacial Surgery, ISSN 0901-5027, 2013, Volume 42, Issue 5, pp. 632 - 636
Abstract There is evidence for a link between the use of systemic bisphosphonates and osteonecrosis of the jaw (ONJ). This condition has the appearance of... 
Surgery | jaw | mucoperiosteal flap | bisphosphonates | osteonecrosis | rat | antibiotics | SURGERY | DEXAMETHASONE | RISK-FACTORS | CANCER-PATIENTS | NECROSIS | DENTISTRY, ORAL SURGERY & MEDICINE | BISPHOSPHONATE-RELATED OSTEONECROSIS | BONE | Molar - surgery | Gingivectomy - methods | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Male | Mouth Mucosa - transplantation | Maxilla - surgery | Surgical Flaps - transplantation | Tooth Socket - surgery | Alendronate - therapeutic use | Tooth Extraction - methods | Time Factors | Injections, Subcutaneous | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Mouth Mucosa - pathology | Disease Models, Animal | Epithelium - pathology | Dexamethasone - administration & dosage | Bone Density Conservation Agents - therapeutic use | Rats | Bone Density Conservation Agents - administration & dosage | Random Allocation | Rats, Sprague-Dawley | Dexamethasone - therapeutic use | Animals | Surgical Flaps - pathology | Wound Healing - physiology | Bisphosphonate-Associated Osteonecrosis of the Jaw - prevention & control | Alendronate - administration & dosage | Periosteum - transplantation | Prevention | Bacterial infections | Dexamethasone | Phosphonates | Media coverage | Bones | Health aspects | Necrosis | Medical and Health Sciences | Medicin och hälsovetenskap | Bisphosphonates
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2017, Volume 40, Issue 6, pp. 739 - 750
Journal Article
Journal of Cranio-Maxillo-Facial Surgery, ISSN 1010-5182, 2016, Volume 44, Issue 10, pp. 1689 - 1693
Journal Article
Journal Article
Bone, ISSN 8756-3282, 05/2018, Volume 110, pp. 141 - 149
Journal Article
BioMed Research International, ISSN 2314-6133, 2018, Volume 2018, pp. 2684924 - 10
Journal Article